Translational Research & Experimental Medicine Company
Purpose-built for small and mid-sized biotechs.
Navigate translational research challenges with confidence.
Drug development is complex. Scientific strategy doesn't have to be. TransAnalitica brings small and mid-sized drug developers credible translational research and experimental medicine competencies — without the overhead or delay.
Smart
Evidence-grounded decisions, less guesswork.
We know which data matters. Every effort is designed around the decision it needs to support, at the inflection points that determine your program's fate.
Fast
Your timeline is the constraint, our momentum keeps up with it.
Biotechs move fast. So do we. No lengthy onboarding, just experienced judgment ready to deploy from day one, so insights land in time to properly act on them.
Impactful
Expertise that doesn't strain the runway.
With transparent time-and-material pricing you pay for expertise applied, not speculative value priced in. Paired with SMART and FAST, more gets done on a budget.Comprehensive support, deployed with precision.
From clinical candidate selection to completed Phase 1 trial, we engage program challenges and deliver tailored guidance and solutions. Reach out with single and specific problems or ideas around end-to-end collaboration.
Explore All Services →High-Dimensional Data Generation & Interpretation
We design, oversee and analyze studies with high-parameter readouts or mine public data and extract the relevant insights from them.
View DetailsPreclinical Study Design, Oversight & Reporting
We write protocols with the clinical question in mind, oversee execution and translate outputs into regulatory-facing reports.
View DetailsTranslational Biomarker Strategy & Assay Development
We build biomarker strategies grounded in your mechanism and mode of action, then help you develop and validate the assays needed to test them in patients.
View DetailsBringing credible solutions directly to your programs.
Biotechs don’t necessarily need full-blown translational research teams from the get-go. A timely advice and uncomplicated expert support can make a huge impact in derisking and accelerating development.
Vinko Tosevski
Founder
My career was born at the intersection of two worlds: my formal training in biology and my personal passion for computers and algorithms. Before computational biology became what it is today, this intersection made me a "data-savvy scientist" and anchored me deeply in experimental medicine, where biological domain knowledge intertwines with statistical rigor to make sense of heterogeneous human data.
Over the past decade at the forefront of molecular profiling for drug development, I've observed a persistent paradox. The field now possesses an unprecedented toolbox of assays and algorithms, yet the impact on drug development still feels underwhelming. The bottleneck is no longer a lack of components, but the interplay between them. We have the pieces; we are just not yet good enough at wiring them together to achieve impactful results.
I founded TransAnalitica to bring exactly this expertise to the table: a thorough understanding of the individual components—biology, assays, data, and algorithms—combined with the experience to integrate them for real-world impact. I choose to partner with small and mid-size biotechs because this is where I find creativity and momentum to strike the perfect balance needed to pave the way to new medicines.
My career was born at the intersection of two worlds: my formal training in biology and my personal passion for computers and algorithms. Before computational biology became what it is today, this intersection made me a "data-savvy scientist" and anchored me deeply in experimental medicine, where biological domain knowledge intertwines with statistical rigor to make sense of heterogeneous human data.
Over the past decade at the forefront of molecular profiling for drug development, I've observed a persistent paradox. The field now possesses an unprecedented toolbox of assays and algorithms, yet the impact on drug development still feels underwhelming. The bottleneck is no longer a lack of components, but the interplay between them. We have the pieces; we are just not yet good enough at wiring them together to achieve impactful results.
I founded TransAnalitica to bring exactly this expertise to the table: a thorough understanding of the individual components—biology, assays, data, and algorithms—combined with the experience to integrate them for real-world impact. I choose to partner with small and mid-size biotechs because this is where I find creativity and momentum to strike the perfect balance needed to pave the way to new medicines.
Translational research support built for modern biotech teams.
Whether you need focused analytical expertise or broader translational strategy support, our scalable engagement model adapts to your program needs.
Start the Conversation